Short Interest in Intelligent Bio Solutions Inc. (NASDAQ:INBS) Declines By 5.1%

Intelligent Bio Solutions Inc. (NASDAQ:INBS) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 427,400 shares, a drop of 5.1% from the December 15th total of 450,500 shares. Based on an average daily volume of 118,600 shares, the short-interest ratio is presently 3.6 days. Currently, 9.1% of the company’s shares are short sold.

Intelligent Bio Solutions Trading Up 6.1 %

NASDAQ:INBS opened at $1.39 on Friday. The company’s 50-day moving average is $1.49 and its two-hundred day moving average is $1.52. Intelligent Bio Solutions has a 1-year low of $1.00 and a 1-year high of $11.70.

Intelligent Bio Solutions (NASDAQ:INBS) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.53) by ($0.17). The firm had revenue of $872.29 million for the quarter. Intelligent Bio Solutions had a negative net margin of 288.35% and a negative return on equity of 147.50%. Equities research analysts predict that Intelligent Bio Solutions will post -1.25 EPS for the current year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.